Media

Our Co-Founder Dr Natasha Ng was awarded the Top Scoring Start-Up (Developer) Abstract Awards at ISCT 2026 in Dublin, Ireland, for Abstract 1531, titled “Combining Genetic Engineering and Scalable Production of Stem Cell-derived Pancreatic Islets to Enable Allogeneic Cell Replacement Therapy in Insulin-dependent Diabetes.” (https://www.isctglobal.org/annual-meeting/abstracts/award-winners)

BetaLife Partners with Nordic Cell Therapy Group for Cell Therapy Advancement

(https://www.linkedin.com/posts/betalife-sg_type1diabetes-celltherapy-ipsc-activity-7470006797257441281-MJef)

(https://www.linkedin.com/posts/nordic-cell-therapy-group_celltherapy-type1diabetes-regenerativemedicine-activity-7470006853025001472-pWOa)

BetaLife was awarded 1st prize in the inaugural ThermoFisher Scientific BioXcelerate award (up to S$50K worth of services and products) (May 2026)

BetaLife was awarded the Enterprise Singapore Startup SG Tech POC grant (S$400K) following a successful panel evaluation and defense (March 2026)

BetaLife was awarded the Enterprise Singapore Startup SG Founder grant (S$50K) following SLINGSHOT and NAMIC startup innovation forum 2025 (https://www.linkedin.com/posts/slingshot2025-namicsif-switchsg-ugcPost-7392482045014368256-ZqgH)

BetaLife was awarded 1st runner-up at the NAMIC Startup Innovation Forum 2025, with a $100,000 project grant (https://www.linkedin.com/posts/namicsg_startupecosystem-additivemanufacturing-3dprinting-activity-7373975106244546560-5OC3)

BetaLife advanced to the top 6 biotech ventures in the Amgen Golden Ticket 2025 (https://www.linkedin.com/posts/nsg-biolabs_biotech-amgengoldenticket-nsgatwork-activity-7351066274002604032-Kipv)

BetaLife won NSG Bio’s Precision Medicine Award 2025, securing a fully-equipped BSL-2 certified laboratory space for one year (https://www.linkedin.com/posts/nsg-biolabs_biotechinnovation-futureofhealthcare-precisionmedicine-activity-7320268627906031634-_n5q1)

Our Co-Founders Dr Adrian Teo and Dr Natasha Ng featured on the One North Stories podcast episode 054 – BetaLife: Regenerative medical for diabetes. Can be listened on Spotify or Apple Music.

(https://open.spotify.com/episode/26TEVx505r5zUMzyk1OwTN?si=QCax3f04RjWvBYkDFPq9DQ)

(https://podcasts.apple.com/ie/podcast/054-betalife-regenerative-medicine-for-diabetes/id1682758136?i=1000676554576)

Our Scientist Dr Beatrice Xuan Ho was awarded the GenScript Life Science Research Grant (LSRG) – 2024 Awardees Cycle 2, securing up to USD 10,000 in research funding. (https://www.genscript.com/grantprogram-2025.html)

Our Scientist Dr Beatrice Xuan Ho was awarded the Stem Cell Engineering Abstract Award at ISCT 2024 in Vancouver, Canada, for Abstract 1214, titled “Genetic Engineering of Stem Cell-Derived Islets for Allogeneic Cell Therapy in Diabetes.” (https://www.isctglobal.org/isct2024/abstracts/award-winners)

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia by Cytiva on 7th Jun 2023 (https://www.cytivalifesciences.com/en/us/news-center/betalife-wins-cytivas-biochallenge-competition-10001)

BetaLife was featured in science news “BetaLife and A*STAR Collaborate to develop next generation cell-based therapy for diabetes treatment” by Genetic Engineering & Biotechnology News on 23nd March 2023 (https://www.genengnews.com/news/betalife-and-astar-agree-to-focus-on-novel-cell-based-therapy-for-diabetes).

Our Co-Founder Dr Adrian Teo featured in a video “Supporting Science Globally: A look into how scientists in Singapore are using organoids” by STEMCELL Technologies on 20th August 2020 (https://www.youtube.com/watch?v=GzMcF4QUdC8).

Our Co-Founder Dr Adrian Teo featured in a story “Entrepreneurial King of the Lab” in the 3rd February 2020 issue of SGInnovate’s white paper on deep tech talent (https://www.sginnovate.com/blog/future-jobs).

Our Co-Founder Dr Adrian Teo and his research team’s work featured in a story “Weaponizing Stem Cells in the War on Diabetes” in Issue 15, July – December 2019, of A*STAR Research.

Our Co-Founder Dr Adrian Teo featured in a cover story “Stem Cells Gaining Importance” in the August 2019 issue of BioSpectrum Asia on stem cell therapies in APAC.

Our Co-Founder Dr Adrian Teo featured on The Stem Cell Podcast Episode 142: “Beta-Cell Proliferation and Diabetes” (https://stemcellpodcast.com/ep-142-b-cell-proliferation-and-diabetes-featuring-dr-adrian-teo; https://content.blubrry.com/stemcellpodcast/SCP142.mp3) held on May 14, 2019.

Our Co-Founders Dr Adrian Teo and Dr Natasha Ng’s research work featured in a story

(https://research.a-star.edu.sg/articles/highlights/getting-to-the-roots-of-early-onset-diabetes)

(https://research.a-star.edu.sg/articles/highlights/gene-trails-lead-to-a-new-view-of-diabetes)